In last trading session, Genelux Corp (NASDAQ:GNLX) saw 0.32 million shares changing hands with its beta currently measuring -0.21. Company’s recent per share price level of $2.39 trading at -$0.11 or -4.40% at ring of the bell on the day assigns it a market valuation of $90.17M. That closing price of GNLX’s stock is at a discount of -146.44% from its 52-week high price of $5.89 and is indicating a premium of 33.05% from its 52-week low price of $1.60. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.26 million shares which gives us an average trading volume of 238.53K if we extend that period to 3-months.
For Genelux Corp (GNLX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.18 in the current quarter.
Genelux Corp (NASDAQ:GNLX) trade information
Upright in the red during last session for losing -4.40%, in the last five days GNLX remained trading in the red while hitting it’s week-highest on Monday, 03/31/25 when the stock touched $2.39 price level, adding 23.89% to its value on the day. Genelux Corp’s shares saw a change of 1.27% in year-to-date performance and have moved -22.40% in past 5-day. Genelux Corp (NASDAQ:GNLX) showed a performance of -35.92% in past 30-days. Number of shares sold short was 2.35 million shares which calculate 13.52 days to cover the short interests.
Genelux Corp (GNLX) estimates and forecasts
This year revenue growth is estimated to fall -97.18% from the last financial year’s standing.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -14.03% during past 5 years. In 2025, company’s earnings growth rate is likely to be around -14.04% while estimates for its earnings growth in next 5 years are of 4.40%.
Genelux Corp (NASDAQ:GNLX)’s Major holders
Insiders are in possession of 12.13% of company’s total shares while institution are holding 12.92 percent of that, with stock having share float percentage of 14.70%. Investors also watch the number of corporate investors in a company very closely, which is 12.92% institutions for Genelux Corp that are currently holding shares of the company.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 873.8 shares of worth $2.09 million or 2.53% of the total outstanding shares. The later fund manager was in possession of 292.09 shares on Dec 31, 2024 , making its stake of worth around $0.7 million in the company or a holder of 0.84% of company’s stock.
